‘Swift Evaluation’ on new drugs approved for the first time in Korea

The government will push forward with a measure for newly-approved new drugs for the first time in Korea to pass insurance benefit propriety evaluations within 100 days in Korea. It has decided to introduce the so-called ‘Fast Track.’

When it comes to innovative pharmaceutical companies, it will work on sophisticate regulations, such as tighten reevaluation standards and plans specialization p...